C M Tench1, I McCurdie, P D White, D P D'Cruz. 1. Bone and Joint Research Unit and. Department of Psychological Medicine, St Bartholomew's and The Royal London School of Medicine and Dentistry, London, UK.
Abstract
OBJECTIVE: This study assessed the prevalence and associations of fatigue in systemic lupus erythematosus (SLE). METHODS: Questionnaires were used to measure self-reported fatigue, disease activity, sleep quality, quality of life, anxiety and depression in 120 out-patients with SLE. RESULTS: Abnormal fatigue was reported by 97 (81%) patients, and 71 (60%) patients reported poor sleep quality. Fatigue correlated negatively with all measures of functioning. Fatigue scores were up to 33% higher in patients with active disease [Systemic Lupus Activity Measure (SLAM >/=3)] than in patients with inactive disease (SLAM >3) (P: < 0.05). There were significant correlations between fatigue and disease activity, sleep quality, anxiety and depression. CONCLUSION: Fatigue is a common complaint of patients with SLE and is associated with diminished ability to function. Apart from treating the primary disease, it may also be worthwhile to treat mood disorders and insomnia in order to reduce fatigue and improve quality of life.
OBJECTIVE: This study assessed the prevalence and associations of fatigue in systemic lupus erythematosus (SLE). METHODS: Questionnaires were used to measure self-reported fatigue, disease activity, sleep quality, quality of life, anxiety and depression in 120 out-patients with SLE. RESULTS:Abnormal fatigue was reported by 97 (81%) patients, and 71 (60%) patients reported poor sleep quality. Fatigue correlated negatively with all measures of functioning. Fatigue scores were up to 33% higher in patients with active disease [Systemic Lupus Activity Measure (SLAM >/=3)] than in patients with inactive disease (SLAM >3) (P: < 0.05). There were significant correlations between fatigue and disease activity, sleep quality, anxiety and depression. CONCLUSION:Fatigue is a common complaint of patients with SLE and is associated with diminished ability to function. Apart from treating the primary disease, it may also be worthwhile to treat mood disorders and insomnia in order to reduce fatigue and improve quality of life.
Authors: Ionita C Ghiran; Mark L Zeidel; Sergey S Shevkoplyas; Jennie M Burns; George C Tsokos; Vasileios C Kyttaris Journal: Arthritis Rheum Date: 2011-02
Authors: A Holvast; A Huckriede; J Wilschut; G Horst; J J C De Vries; C A Benne; C G M Kallenberg; M Bijl Journal: Ann Rheum Dis Date: 2005-12-01 Impact factor: 19.103
Authors: Mary A Mahieu; Grace E Ahn; Joan S Chmiel; Dorothy D Dunlop; Irene B Helenowski; Pamela Semanik; Jing Song; Susan Yount; Rowland W Chang; Rosalind Ramsey-Goldman Journal: Rheumatol Int Date: 2018-01-04 Impact factor: 2.631
Authors: Jacques Pouchot; Raheem B Kherani; Rollin Brant; Diane Lacaille; Allen J Lehman; Stephanie Ensworth; Jacek Kopec; John M Esdaile; Matthew H Liang Journal: J Clin Epidemiol Date: 2008-03-21 Impact factor: 6.437